Senior IR Expertise Target firms seeking high-touch investor relations with senior professionals who bring 25+ years in healthcare investment banking, equity research, IR, and PR to build credibility with buy-side and sell-side stakeholders.

Life Sciences Focus Capitalize on specialization in life sciences and healthcare to offer tailored messaging for IPOs, financings, M&A, partnerships, and litigation, aligning communications programs with clinical readouts and biotech development milestones.

Global C-Suite Partnering Position as a 24/7 partner that functions as an extension of the C-suite, appealing to companies needing urgent, hands-on support during funding rounds, clinical milestones, or crisis communications.

Investor Network Leverage Leverage extensive U.S. investment community contacts and longstanding relationships with buy/sell-side analysts, bankers, and journalists to accelerate client visibility and funding conversations.

Small Firm Advantage Highlight agility and tailored programs of a small, senior-led firm to win mid-sized life sciences companies that require individualized IR and PR strategies without the overhead of larger agencies.